Published in J Am Coll Cardiol on January 10, 2012
Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science (2013) 3.22
The pathogenesis of cardiac fibrosis. Cell Mol Life Sci (2013) 1.96
Pathophysiology of LV Remodeling in Survivors of STEMI: Inflammation, Remote Myocardium, and Prognosis. JACC Cardiovasc Imaging (2015) 1.69
Monocyte and macrophage heterogeneity in the heart. Circ Res (2013) 1.63
Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarction. Circ Res (2014) 1.52
Inflammatory processes in cardiovascular disease: a route to targeted therapies. Nat Rev Cardiol (2016) 1.46
Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome. Circ Cardiovasc Imaging (2016) 1.44
Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice. Circulation (2013) 1.30
Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages. Exp Mol Med (2014) 1.26
Cardiac macrophages and their role in ischaemic heart disease. Cardiovasc Res (2014) 1.21
Polymeric nanoparticle PET/MR imaging allows macrophage detection in atherosclerotic plaques. Circ Res (2013) 1.11
PET imaging of inflammation biomarkers. Theranostics (2013) 1.04
Macrophages mediate cardioprotective cellular postconditioning in acute myocardial infarction. J Clin Invest (2015) 1.00
Proliferation and Recruitment Contribute to Myocardial Macrophage Expansion in Chronic Heart Failure. Circ Res (2016) 0.99
Competitive advantage of PET/MRI. Eur J Radiol (2013) 0.98
A network study of chinese medicine xuesaitong injection to elucidate a complex mode of action with multicompound, multitarget, and multipathway. Evid Based Complement Alternat Med (2013) 0.97
Advance of molecular imaging technology and targeted imaging agent in imaging and therapy. Biomed Res Int (2014) 0.94
Myocardial infarction causes inflammation and leukocyte recruitment at remote sites in the myocardium and in the renal glomerulus. Inflamm Res (2013) 0.94
Monocyte and macrophage contributions to cardiac remodeling. J Mol Cell Cardiol (2015) 0.93
Molecular imaging in atherosclerosis: FDG PET. Curr Atheroscler Rep (2012) 0.91
Magnetic resonance imaging investigation of macrophages in acute cardiac allograft rejection after heart transplantation. Circ Cardiovasc Imaging (2013) 0.86
Cardiovascular molecular imaging: the road ahead. J Nucl Med (2012) 0.86
FDG-PET reveals improved cardiac regeneration and attenuated adverse remodelling following Sitagliptin + G-CSF therapy after acute myocardial infarction. Eur Heart J Cardiovasc Imaging (2015) 0.85
Targeting post-infarct inflammation by PET imaging: comparison of (68)Ga-citrate and (68)Ga-DOTATATE with (18)F-FDG in a mouse model. Eur J Nucl Med Mol Imaging (2014) 0.84
Imaging systemic inflammatory networks in ischemic heart disease. J Am Coll Cardiol (2015) 0.84
Personalized nanomedicine advancements for stem cell tracking. Adv Drug Deliv Rev (2012) 0.84
Cardiac microvascular barrier function mediates the protection of Tongxinluo against myocardial ischemia/reperfusion injury. PLoS One (2015) 0.84
Cells and iron oxide nanoparticles on the move: magnetic resonance imaging of monocyte homing and myocardial inflammation in patients with ST-elevation myocardial infarction. Circ Cardiovasc Imaging (2012) 0.82
State of the Art in Cardiac Hybrid Technology: PET/MR. Curr Cardiovasc Imaging Rep (2013) 0.81
Up-regulated TLR4 in cardiomyocytes exacerbates heart failure after long-term myocardial infarction. J Cell Mol Med (2015) 0.81
MRI and PET in mouse models of myocardial infarction. J Vis Exp (2013) 0.80
Diverse Applications of Nanomedicine. ACS Nano (2017) 0.80
Imaging macrophage development and fate in atherosclerosis and myocardial infarction. Immunol Cell Biol (2012) 0.79
Clinically relevant strategies for lowering cardiomyocyte glucose uptake for 18F-FDG imaging of myocardial inflammation in mice. Eur J Nucl Med Mol Imaging (2014) 0.79
Clinical and research applications of simultaneous positron emission tomography and MRI. Br J Radiol (2013) 0.79
Pressure-overload-induced right heart failure. Pflugers Arch (2014) 0.78
SPECT imaging of inflammatory response in ischemic-reperfused rat hearts using a 99mTc-labeled dual-domain cytokine ligand. J Nucl Med (2013) 0.78
Intramyocardial hemorrhage: an enigma for cardiac MRI? Biomed Res Int (2015) 0.78
Impaired autophagy contributes to adverse cardiac remodeling in acute myocardial infarction. PLoS One (2014) 0.78
Novel Noninvasive Nuclear Medicine Imaging Techniques for Cardiac Inflammation. Curr Cardiovasc Imaging Rep (2017) 0.78
Polyglucose nanoparticles with renal elimination and macrophage avidity facilitate PET imaging in ischaemic heart disease. Nat Commun (2017) 0.77
Image-guided therapies for myocardial repair: concepts and practical implementation. Eur Heart J Cardiovasc Imaging (2013) 0.77
Macrophages in the Remodeling Failing Heart. Circ Res (2016) 0.76
Advances in molecular imaging of atherosclerosis and myocardial infarction: shedding new light on in vivo cardiovascular biology. Am J Physiol Heart Circ Physiol (2012) 0.76
Monocytes on the scar's edge. J Am Coll Cardiol (2012) 0.76
Toll-like receptor 4 mediates the inflammatory responses and matrix protein remodeling in remote non-ischemic myocardium in a mouse model of myocardial ischemia and reperfusion. PLoS One (2015) 0.75
Cardiac FDG-PET: a straight forward tool with high potential. Eur Heart J Cardiovasc Imaging (2015) 0.75
Impact of thoracic surgery on cardiac morphology and function in small animal models of heart disease: a cardiac MRI study in rats. PLoS One (2013) 0.75
Highlights of the year in JACC 2012. J Am Coll Cardiol (2013) 0.75
Multiparametric Imaging of Organ System Interfaces. Circ Cardiovasc Imaging (2017) 0.75
Theranostic Nucleic Acid Binding Nanoprobe Exerts Anti-inflammatory and Cytoprotective Effects in Ischemic Injury. Theranostics (2017) 0.75
Targeting Amino Acid Metabolism for Molecular Imaging of Inflammation Early After Myocardial Infarction. Theranostics (2016) 0.75
Recent Advances in Nuclear Cardiology. Nucl Med Mol Imaging (2016) 0.75
Ferumoxytol-enhanced magnetic resonance imaging assessing inflammation after myocardial infarction. Heart (2017) 0.75
Role of molecular imaging with positron emission tomographic in aortic aneurysms. J Thorac Dis (2017) 0.75
Periodontal-induced chronic inflammation triggers macrophage secretion of Ccl12 to inhibit fibroblast-mediated cardiac wound healing. JCI Insight (2017) 0.75
Targeted PET imaging strategy to differentiate malignant from inflamed lymph nodes in diffuse large B-cell lymphoma. Proc Natl Acad Sci U S A (2017) 0.75
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med (2007) 11.51
Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science (2009) 10.47
Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation (1990) 9.74
The inflammatory response in myocardial infarction. Cardiovasc Res (2002) 7.92
Immune cell migration in inflammation: present and future therapeutic targets. Nat Immunol (2005) 7.47
Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med (2008) 4.54
Imaging of atherosclerotic cardiovascular disease. Nature (2008) 4.14
Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation (2007) 3.85
Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction. J Am Coll Cardiol (2009) 3.44
Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation (2010) 3.37
Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction:a possible role for left ventricular remodeling. J Am Coll Cardiol (2002) 3.27
Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis. J Am Coll Cardiol (2010) 2.90
Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation (2003) 2.87
Simultaneous in vivo positron emission tomography and magnetic resonance imaging. Proc Natl Acad Sci U S A (2008) 2.50
Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina. JACC Cardiovasc Imaging (2010) 2.38
Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation. J Nucl Med (2009) 2.21
Hybrid PET-optical imaging using targeted probes. Proc Natl Acad Sci U S A (2010) 2.17
Noninvasive visualization of coronary artery endothelial function in healthy subjects and in patients with coronary artery disease. J Am Coll Cardiol (2010) 2.09
Significance of total and differential leucocyte count in patients with acute myocardial infarction treated with primary coronary angioplasty. Eur Heart J (2006) 1.99
Activatable magnetic resonance imaging agent reports myeloperoxidase activity in healing infarcts and noninvasively detects the antiinflammatory effects of atorvastatin on ischemia-reperfusion injury. Circulation (2008) 1.97
Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications. J Am Coll Cardiol (2009) 1.93
Multimodality cardiovascular molecular imaging, Part II. Circ Cardiovasc Imaging (2009) 1.82
Angiotensin-converting enzyme inhibition prevents the release of monocytes from their splenic reservoir in mice with myocardial infarction. Circ Res (2010) 1.82
Detection of macrophages in aortic aneurysms by nanoparticle positron emission tomography-computed tomography. Arterioscler Thromb Vasc Biol (2011) 1.66
Extracellular matrix roles during cardiac repair. Life Sci (2010) 1.32
Molecular imaging of coronary atherosclerosis and myocardial infarction: considerations for the bench and perspectives for the clinic. Circ Res (2011) 1.25
Coronary magnetic resonance angiography. J Magn Reson Imaging (2007) 1.18
Myocyte death in heart failure. Curr Opin Cardiol (1996) 1.05
Radionuclide imaging of myocardial metabolism. Circ Cardiovasc Imaging (2010) 1.02
Integration of multimodality imaging data for radiotherapy treatment planning. Int J Radiat Oncol Biol Phys (1991) 1.00
Advances in clinical applications of cardiovascular magnetic resonance imaging. Heart (2008) 0.96
Isochronous assessment of cardiac metabolism and function in mice using hybrid PET/MRI. J Nucl Med (2010) 0.86
Cardiovascular MRI: its current and future use in clinical practice. Expert Rev Cardiovasc Ther (2007) 0.85
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers. Nat Med (2008) 14.47
Restoration of p53 function leads to tumour regression in vivo. Nature (2007) 12.62
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med (2007) 11.51
Imaging in the era of molecular oncology. Nature (2008) 11.10
Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science (2009) 10.47
Looking and listening to light: the evolution of whole-body photonic imaging. Nat Biotechnol (2005) 9.57
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med (2003) 9.09
Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest (2007) 8.65
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell (2012) 7.36
Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol (2002) 6.06
Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther (2005) 6.04
Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. Proc Natl Acad Sci U S A (2006) 5.90
Fluorescence molecular tomography resolves protease activity in vivo. Nat Med (2002) 5.53
The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies. Cancer Cell (2006) 5.34
Arthritis critically dependent on innate immune system players. Immunity (2002) 5.31
Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell (2002) 5.11
The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell (2010) 5.11
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet (2011) 4.67
The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science (2013) 4.60
Myocardial infarction accelerates atherosclerosis. Nature (2012) 4.48
Chip-NMR biosensor for detection and molecular analysis of cells. Nat Med (2008) 4.29
Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation (2007) 4.20
Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med (2013) 4.14
Magnetic relaxation switches capable of sensing molecular interactions. Nat Biotechnol (2002) 4.13
Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Proc Natl Acad Sci U S A (2004) 4.12
Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat Med (2012) 4.11
A spatially and temporally restricted mouse model of soft tissue sarcoma. Nat Med (2007) 3.96
Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol (2011) 3.95
Tetrazine-based cycloadditions: application to pretargeted live cell imaging. Bioconjug Chem (2008) 3.93
Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity (2006) 3.92
Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation (2007) 3.85
Fast and sensitive pretargeted labeling of cancer cells through a tetrazine/trans-cyclooctene cycloaddition. Angew Chem Int Ed Engl (2009) 3.63
Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation (2006) 3.57
Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation (2007) 3.51
Molecular imaging in drug discovery and development. Nat Rev Drug Discov (2003) 3.44
Arterial inflammation in patients with HIV. JAMA (2012) 3.42
Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease. Proc Natl Acad Sci U S A (2006) 3.38
Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation (2010) 3.37
Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev (2008) 3.34
A secreted luciferase for ex vivo monitoring of in vivo processes. Nat Methods (2008) 3.31
Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science (2013) 3.22
Intravital imaging. Cell (2011) 3.18
Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation (2007) 3.12
Myocardial structure and function differ in systolic and diastolic heart failure. Circulation (2006) 3.11
Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery. Nat Nanotechnol (2012) 3.09
A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J (2009) 3.06
Presence of older thrombus is an independent predictor of long-term mortality in patients with ST-elevation myocardial infarction treated with thrombus aspiration during primary percutaneous coronary intervention. Circulation (2008) 2.96
Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury. J Am Coll Cardiol (2009) 2.94
Diagnostic accuracy of combined intracoronary pressure and flow velocity information during baseline conditions: adenosine-free assessment of functional coronary lesion severity. Circ Cardiovasc Interv (2012) 2.93
Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J Exp Med (2012) 2.92
Multivalent effects of RGD peptides obtained by nanoparticle display. J Med Chem (2006) 2.91
MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res (2007) 2.90
Randomized trial comparing same-day discharge with overnight hospital stay after percutaneous coronary intervention: results of the Elective PCI in Outpatient Study (EPOS). Circulation (2007) 2.90
Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis. J Am Coll Cardiol (2010) 2.90
Near-infrared fluorescence: application to in vivo molecular imaging. Curr Opin Chem Biol (2009) 2.89
An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nat Mater (2006) 2.84